Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Shares, no par value, of Meridian Bioscience, Inc., an Ohio corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: February 4, 2022
Impactive Capital LP | |||
By: | Impactive Capital LLC | ||
its General Partner | |||
By: | /s/ Lauren Taylor Wolfe | ||
Name: | Lauren Taylor Wolfe | ||
Title: | Managing Member |
Impactive Capital LLC | |||
By: | /s/ Lauren Taylor Wolfe | ||
Name: | Lauren Taylor Wolfe | ||
Title: | Managing Member |
/s/ Lauren Taylor Wolfe | |
Lauren Taylor Wolfe |
/s/ Christian Asmar | |
Christian Asmar |